Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory Study on the Anti-inflammatory Effects of Extended-Release Pemafibrate in Patients with Dyslipidemia
jRCT1071260020Completed
- Sponsor
- None, Self-Directed Research
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of pemafibrate in dyslipidemia (2 arms), sponsored by None, Self-Directed Research. Primary endpoint: Change in inflammatory markers from baseline at 24 weeks. Started Jun 2024; status: completed.
02
Drugs
pemafibrate
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on jRCT1071260020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1071260020.